NFKB1 and metastatic malignant neoplasm: We also examined whether ampelopsin could suppress TNF-α-stimulated NF-κB signaling, because the TNF-α/NF-κB pathway has been known to enhance migration, invasion, and tumorigenesis in metastatic cancer [44].